Edwards might be primarily known for its TAVR systems, but the company has been making some interesting forays into the artificial intelligence realm.
News & Features
What can manufacturers do so their plastic medical devices don't crack or degrade under more-stringent cleaning?
University of Texas Engineers have developed a noninvasive way to simulate repairs to the heart's mitral valve allowing surgeons to provide patient-specific treatments.
The NAVIGATE study evaluating electromagnetic navigation bronchoscopy (ENB) procedures using the superDimension navigation system to aid in lung cancer diagnosis, staging, and treatment.
The Tempe, AZ-based company has raised $10M in a series A to help further commercialize the Gamma Tile, surgically targeted radiation therapy for patients with brain tumors.
Stryker reported strong performance in the fourth quarter of 2018 with a record number of robots installed and a healthy order book going into 2019.
Biodesix and MRM are the latest diagnostic firms to enter into a partnership geared at the early detection of lung cancer.
A $100M joint venture is expected to improve access to advanced rehabilitation technologies for Chinese stroke and spinal cord injury patients.
The Massachusetts Medical Device Development Center is hosting its annual startup competition to identify disruptive medtech and biotech companies. Up to 20 finalists will become eligible to win a share the $200,000 purse of sponsor-provided, in-kind services.
A chemist and biocompatibility expert offers the latest insights and predictions on medtech biocompatibility testing.
In addition, the company said it has received a breakthrough device designation for the test, which predicts amyloid PET scan results in patients.
For a holistic approach to successful design, integrate as many engineering disciplines into the design cycle and keep an eye on materials science and connectivity advances.
The Marlborough, MA-based company’s device treats benign prostatic hyperplasia, and was obtained when it acquired NxThera for $406 million.